{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:53:09Z","timestamp":1788051189696,"version":"build-2784847793"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Poor graft function (PGF) represents a serious and potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, its etiological risk factors and prognostic implications remain inadequately defined within pediatric populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study was conducted on 175 pediatric patients undergoing allo-HSCT between 30 June 2018, and 31 December 2022. Patients were stratified into PGF (n = 30) and good graft function (GGF, n = 145) groups. Multivariate logistic regression identified risk factors for PGF, while Cox proportional hazards models evaluated mortality-associated variables. Survival outcomes were analyzed using Kaplan-Meier curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Key findings encompass: (1) PGF Risk Factors: Multivariable analysis identified four independent predictors of PGF: age \u226510 years at transplantation (OR = 29.27, 95%CI: 5.70\u2013150.21, P &amp;lt; 0.001), HLA mismatch (OR = 4.11, 95%CI: 1.45\u201311.65, P = 0.008), cytomegalovirus (CMV) infection (OR = 7.64, 95%CI: 2.31\u201325.21, P = 0.001), and BK virus (BKV) infection (OR = 12.22, 95%CI: 2.49\u201359.89, P = 0.002); The model\u2019s predictive performance by ROC analysis yielded an AUC of 0.886 (95%CI: 0.83\u20130.94; P &amp;lt; 0.001). (2) Survival Analysis: the 4-year overall survival (OS) was profoundly inferior in the PGF cohort compared to the GGF cohort (49.4% \u00b1 10.3% vs. 90.2% \u00b1 2.5%, P &amp;lt; 0.001). (3) Predictors of Mortality: Cox regression identified PGF (HR = 2.39, 95%CI: 1.02\u20135.59, P = 0.044), acute graft-versus-host disease (grade I\/II, HR = 3.43, 95%CI: 1.29\u20139.15, P = 0.014; grade III\/IV, HR = 8.92, 95%CI: 3.19\u201324.96, P &amp;lt; 0.001), hemorrhagic cystitis (HR = 3.18, 95%CI: 1.37\u20137.39, P = 0.007), and severe pneumonia (HR = 4.42, 95%CI: 1.92\u201310.19, P &amp;lt; 0.001) as independent predictors of early mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Age \u226510 years at transplantation, HLA mismatch, CMV infection, or BK viremia identifies a high-risk cohort of pediatric allo-HSCT recipients who require intensified monitoring for PGF, underscoring an urgent need for effective preventive and therapeutic interventions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcell.2025.1651658","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:41:07Z","timestamp":1759902067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors and prognosis of poor graft function after allogeneic hematopoietic stem cell transplantation in pediatric: a retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Guanxiu","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/bmt.2016.98","article-title":"Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis","volume":"51","author":"Alchalby","year":"2016","journal-title":"Bone Marrow Transpl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/bmt.2016.7","article-title":"Hematopoietic stem cell transplantation for homozygous \u03b2-thalassemia and \u03b2-thalassemia\/hemoglobin E patients from haploidentical donors","volume":"51","author":"Anurathapan","year":"2016","journal-title":"Bone Marrow Transpl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/16078454.2022.2042064","article-title":"Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes","volume":"27","author":"Chen","year":"2022","journal-title":"Hematology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood.2020010028","article-title":"Immune control of cytomegalovirus reactivation in stem cell transplantation","volume":"139","author":"Degli-Esposti","year":"2022","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02468.x","article-title":"Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: Graft-Versus-Host disease, donor type, cytomegalovirus infections and cell dose","volume":"112","author":"Dominietto","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5114\/ceji.2019.89843","article-title":"Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children","volume":"45","author":"Janeczko-Czarnecka","year":"2020","journal-title":"Cent. Eur. J. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.08.004","article-title":"Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights","volume":"56","author":"Kong","year":"2019","journal-title":"Semin. Hematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"896034","DOI":"10.3389\/fimmu.2022.896034","article-title":"The incidence, outcomes, and risk factors of secondary poor graft function in haploidentical hematopoietic stem cell transplantation for acquired aplastic anemia","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11684-017-0595-7","article-title":"Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation","volume":"13","author":"Lv","year":"2019","journal-title":"Front. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8497","DOI":"10.1002\/cam4.4353","article-title":"Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: a single-center retrospective study","volume":"10","author":"Lv","year":"2021","journal-title":"Cancer Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbmt.2016.02.002","article-title":"Feasibility and outcome of haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide for children and adolescents with hematologic malignancies: an AIEOP-GITMO retrospective multicenter study","volume":"22","author":"M","year":"2016","journal-title":"Biol. blood marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.bbmt.2019.12.003","article-title":"Use of thrombopoietin receptor agonists in prolonged thrombocytopenia after hematopoietic stem cell transplantation","volume":"26","author":"Mahat","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"911174","DOI":"10.3389\/fimmu.2022.911174","article-title":"Recent advancements in poor graft function following hematopoietic stem cell transplantation","volume":"13","author":"Man","year":"2022","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41598-021-82160-0","article-title":"BK virus infection and outcome following kidney transplantation in childhood","volume":"11","author":"McCaffrey","year":"2021","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/bmt.2017.93","article-title":"Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection","volume":"52","author":"Ohmoto","year":"2017","journal-title":"Bone Marrow Transpl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the european society for blood and marrow transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/10428194.2021.1872072","article-title":"Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation","volume":"62","author":"Prabahran","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1182\/bloodadvances.2021004537","article-title":"Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation","volume":"6","author":"Prabahran","year":"2022","journal-title":"Blood Adv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v13081530","article-title":"Consequence of histoincompatibility beyond GvH-Reaction in cytomegalovirus disease associated with allogeneic hematopoietic cell transplantation: change of paradigm","volume":"13","author":"Reddehase","year":"2021","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR task force position statement on standardized terminology and guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1106464","DOI":"10.3389\/fimmu.2023.1106464","article-title":"Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: a multicenter prospective analysis","volume":"14","author":"Servais","year":"2023","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"877.e1","DOI":"10.1016\/j.jtct.2021.07.012","article-title":"Outcomes with CD34-Selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","author":"Shahzad","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3760\/cma.j.issn.0253-2727.2020.07.001","article-title":"Expert consensus on allogeneic hematopoietic stem cell Transplantation in China for the treatment of hematological diseases (III.) - acute graft-versus-host disease (2020 Edition)","volume":"41","year":"2020","journal-title":"Chin. J. Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00277-015-2440-x","article-title":"The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation","volume":"94","author":"Sun","year":"2015","journal-title":"Ann. Hematol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00277-019-03715-w","article-title":"Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation","volume":"98","author":"Sun","year":"2019","journal-title":"Ann. Hematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12185-011-0988-3","article-title":"The effect of iron overload and chelation on erythroid differentiation","volume":"95","author":"Taoka","year":"2012","journal-title":"Int. J. Hematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.7150\/ijms.6337","article-title":"Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Xiao","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.bbmt.2019.05.036","article-title":"Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Zhao","year":"2019","journal-title":"Biol. Blood Marrow Transpl."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1651658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:41:08Z","timestamp":1759902068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1651658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":30,"alternative-id":["10.3389\/fcell.2025.1651658"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1651658","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1651658"}}